Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)

NCT01510756 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped slow enrollment

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Sorafenib

Sponsor

Thomas Kipps

Collaborators

[object Object]